Granular lymphocytic leukemia derived from gamma delta T-cell expressing cytotoxic molecules

T Saito1, K Togitani, J Murakami

  • 1Hematology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Leukemia Research
|February 28, 2001
PubMed

Insights

This report details an exceptionally rare case of granular lymphocytic leukemia originating from gamma delta T-cells (gamma delta T-GLL). This finding highlights a unique subtype of leukemia with distinct immunophenotypic characteristics.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Granular lymphocytic leukemia (GLL) is a rare hematologic malignancy.
  • Gamma delta (γδ) T-cells represent a distinct lineage of T lymphocytes with unique functions.
  • The occurrence of GLL specifically derived from γδ T-cells is exceptionally uncommon.

Observation:

  • A patient presented with leukocytosis (25.7 x 10^9/L) comprising 94% atypical lymphocytes with cytoplasmic granules.
  • Immunophenotyping revealed lymphocytes positive for CD2, CD3, CD5, CD7, CD56, and T-cell receptor (TCR) γδ, but negative for CD4, CD8, CD57, TCR αβ, and B-cell antigens.
  • Cytotoxic molecules T-cell intracellular antigen-1 (TIA-1) and granzyme B were positive, indicating cytotoxic potential.

Findings:

  • Southern blot analysis confirmed T-cell receptor J gamma and C beta gene rearrangement, with germline configuration of the JH gene.
  • Human T-cell leukemia virus type-I (HTLV-I) infection was ruled out through serological and molecular testing.
  • Imaging revealed splenomegaly without lymphadenopathy.

Implications:

  • The case establishes a diagnosis of gamma delta T-cell granular lymphocytic leukemia (γδ T-GLL).
  • The patient was managed conservatively with over 4 years of follow-up without therapeutic intervention.
  • This case contributes to the understanding of rare T-cell malignancies and the spectrum of γδ T-cell neoplasms.